Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature

BACKGROUND: The optimal first-line chemotherapy for ovarian carcinosarcoma has not yet been determined. We therefore sought to determine the progression-free survival (PFS) and overall survival (OS) for patients with ovarian carcinosarcoma treated at our institution with different first-line chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Brackmann, Melissa, Stasenko, Marina, Uppal, Shitanshu, Erba, Jake, Reynolds, R. Kevin, McLean, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810191/
https://www.ncbi.nlm.nih.gov/pubmed/29426293
http://dx.doi.org/10.1186/s12885-018-4082-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810191/
https://www.ncbi.nlm.nih.gov/pubmed/29426293
http://dx.doi.org/10.1186/s12885-018-4082-6

Ejemplares similares